Casdin Partners Master Fund, L.P. - 19 May 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
10%+ Owner
Signature
Casdin Partners Master Fund LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member
Issuer symbol
BLFS
Transactions as of
19 May 2023
Net transactions value
+$1,673,220
Form type
4
Filing time
23 May 2023, 17:46:54 UTC
Previous filing
19 May 2023
Next filing
11 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock, par value $.001 per share Purchase $1,127,430 +50,000 +67% $22.55 125,027 19 May 2023 See footnote F1, F2
transaction BLFS Common Stock, par value $.001 per share Purchase $545,790 +24,973 +20% $21.86 150,000 22 May 2023 See footnote F2
holding BLFS Common Stock, par value $.001 per share 7,571,535 19 May 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $22.07753 to $23.0197. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.
F3 The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to the Master Fund, (ii) Casdin GP, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.